MEDICAL AUTOMATION EXPERTS


Terry Sharrer's bio:

Dr. Sharrer began as Executive Director, Medical Innovation and Transformation Institute, with the Inova Health System (Fairfax, VA) in July 2007. Formerly, he was the Curator of Health Sciences at the National Museum of American History, Smithsonian Institution, where he had worked for thirty-six years.

Terry Sharrer speaks and writes about a range of life science subjects. In 1987, he co-organized an exhibition titled "The Search for Life: Genetic Technology in the 20th Century." This show also was the inaugural exhibition for the DNA Learning Center at Cold Spring Harbor Laboratory in New York. He has done video documentaries on the Human Genome Project, the beginning of gene therapy, and the molecular biology of cancer. He holds a PhD in history from the University of Maryland, has authored some three dozen publications-including A Kind of Fate, Agricultural Change in Virginia, 1861-1920 (about the biological consequences of the Civil War and the beginning of germ theory practices, Iowa State University Press, 2000)-and currently is writing a history of molecular medicine. For outreach work, has served as Chairman of the Board of Directors of the National Foundation for Cancer Research (Bethesda, MD), board member of the Carilion Biomedical Institute (Roanoke, VA), board member, Immune Deficiency Foundation (Towson, MD), and board member, Inova Fairfax Hospital Cancer Advisory Committee (Fairfax, VA).

Currently, his public service includes: board member of the Fund for Inherited Disease Research (Bryn Mawr, PA); and Science Advisor, for the Loudoun County, VA Department of Economic Development, the Clarke County VA Education Foundation, and the Arizona Science Alliance. With his wife Patty, and sons Alex, age 13, and Nicholas, age 17, he lives in Hamilton, Loudoun County, VA.

Disclosure: G. Terry Sharrer, PhD has stock dividends in Merck and Pfizer.

Terry Sharrer's posts:

Neurology of Stuttering

August 13, 2024 | | Posted in Newsletter

Localization of stuttering based on causal brain lesions
“Of the many theoretical accounts of stuttering proposed previously, our [researchers at the [MORE]

First Personalized Cancer Vaccine

August 6, 2024 | | Posted in Newsletter

NHS patients in England to be offered trials for world-first cancer vaccine
“Thousands of patients in England are to be fast-tracked [MORE]

“Invisible Tweezers” in Minimally Invasive Surgery

August 6, 2024 | | Posted in Newsletter

“Invisible Tweezers” in Minimally Invasive Surgery
“Here, we [at Virginia Tech] present chirality-tunable acoustic vortex tweezers that can tune acoustic vortex [MORE]

Reverse Transcription Gene Editing

August 6, 2024 | | Posted in Newsletter

Researchers elucidate the spatial structure and molecular mechanisms of ‘prime editor,’ a novel gene-editing tool
“The prime editor system composed of [MORE]

Philips ePatch Heart Monitor

August 6, 2024 | | Posted in Newsletter

Philips ePatch Heart Monitor
“Applications include monitoring patients for AF [atrial fibrillation] after cardiac ablation therapy or heart valve replacement procedures, [MORE]

Cell by Cell Changes in Xenotransplantation

August 6, 2024 | | Posted in Newsletter

Cellular dynamics in pig-to-human kidney xenotransplantation
“Early trials of porcine kidney xenotransplantation have been performed on brain-dead human recipients, but the [MORE]

Clinical Trial in a Dish

August 6, 2024 | | Posted in Newsletter

Parallel Bio serves up ‘clinical trial in a dish’ as animal model alternative
“Immunology startup Parallel Bio has released a model [MORE]

Printing Bioelectronics Fibers on Skin

August 6, 2024 | | Posted in Newsletter

Imperceptible augmentation of living systems with organic bioelectronic fibres
“Here we [University of Cambridge] report imperceptible augmentation of living systems through [MORE]

An Adeno-Associated Virus with Enhanced Ability to Cross the Brain-Blood Barrier

July 30, 2024 | | Posted in Newsletter

New gene delivery vehicle shows promise for human brain gene therapy
“In a new study published in Science, the team showed [MORE]

Printing Personalized Pills

July 30, 2024 | | Posted in Newsletter

Printing personalised pharmaceutical tablets
“In this paper we [at University of Nottingham, UK] demonstrate how two dissimilar materials, one water soluble [MORE]

Polygenic Embryo Screening

July 30, 2024 | | Posted in Newsletter

Public attitudes, interests, and concernsregarding polygenic embryo screening
“Polygenic embryo screening (PES), also known as preimplantation genetic testing for polygenic outcomes [MORE]

Evolution of Molecular Fingerprints

July 30, 2024 | | Posted in Newsletter

Evolutionary algorithm generates tailored “Molecular Fingerprints”
“A team led by Prof Frank Glorius from the Institute of Organic Chemistry at the [MORE]

Anellovirus Vectors in Gene Therapy

July 30, 2024 | | Posted in Newsletter

Ring’s ‘new class of viral vector’ is re-dosable in primates, overcoming key challenge of AAVs
“AAVs are the most commonly used [MORE]

Blurred Tomography

July 30, 2024 | | Posted in Newsletter

Sharper future- optical fabrication with rapid 3D printing
“A new 3D printing method, called blurred tomography, could significantly enhance the production [MORE]